The German-headquartered Bayer, a multinational pharma and biotech giant, has secured a long-term structured renewable energy credit (REC) power purchase agreement with Read More
Investors are demanding around 2.2 billion euros ($2.5 billion) from Bayer (BAYGn.DE) as part of a possible class action lawsuit in Germany over Read More
